Observational studyScientific reports2023

Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.

Tomoya Mita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.